Functionalized Polymeric Microspheres for Stable Radionuclide Loading
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current radioactive microspheres for brachytherapy face challenges such as high production costs, unwanted radioisotope impurities, poor injectability, non-uniform distribution, and radiolabeling instability, leading to adverse reactions and inefficiencies in tumor treatment.
Innovation Solution
Development of functionalized polymeric microspheres through a method involving styrene monomer reaction, radiation-induced graft polymerization, and radionuclide adsorption, resulting in microspheres with enhanced stability, biocompatibility, and uniform distribution, suitable for intravascular brachytherapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If Y-90 glass microspheres are prepared by neutron activation, then radionuclide loading is achieved, but production costs increase and long-lived radioisotope impurities are generated
Solution Approach 1:
The patent changes the radionuclide loading method from neutron activation to a chemical chelation process using DOTA or NOTA ligands. This parameter change eliminates the need for nuclear reactor facilities, reduces production costs, and avoids generation of long-lived radioisotope impurities while maintaining effective radionuclide loading on the microspheres
Solution Approach 2:
The patent introduces DOTA or NOTA ligands as intermediary molecules that mediate the binding between the radionuclide and the microsphere surface. This intermediary approach enables controlled radionuclide attachment through chelation chemistry, replacing the direct neutron activation method and providing better control over radionuclide loading and stability
2Quantity of substance
If Y-90 glass microspheres are used, then radionuclide loading is achieved, but density is much higher than blood causing deposition in proximal blood vessels
Solution Approach 1:
The patent changes the material composition of the microspheres from dense glass to less dense polymeric materials such as poly(lactic-co-glycolic acid) (PLGA), poly(lactic acid) (PLA), or poly(epsilon-caprolactone) (PCL). This parameter change reduces the density of microspheres to be closer to that of blood, improving injectability and preventing deposition in proximal blood vessels while maintaining effective radionuclide loading through ligand attachment
3Ease of operation
If Y-90 resin microspheres are used, then injectability is improved, but radiolabeling stability is poor causing radionuclide release
Solution Approach 1:
The patent introduces DOTA or NOTA ligands as intermediary chelating agents that provide stable coordination chemistry for radionuclide attachment. These ligands form thermodynamically stable complexes with radionuclides such as 177Lu, 90Y, or 188Re, ensuring radiolabeling stability and preventing radionuclide release while maintaining the improved injectability of polymeric microspheres
Solution Approach 2:
The patent creates composite microspheres combining polymeric materials (for biocompatibility and injectability) with chelating ligands (for radiolabeling stability). This composite structure integrates the advantages of both materials: the polymeric core provides suitable density and biocompatibility, while the surface-attached DOTA or NOTA ligands ensure stable radionuclide binding
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered radioactive polymeric microspheres achieve high radionuclide adsorption rates, low release rates, and uniform distribution, ensuring effective tumor treatment with improved safety and cost-effectiveness, suitable for various cancer types including liver tumors.
Implementation Method 1
subjecting the polymeric microsphere to radiation-induced graft polymerization with a functional monomer to obtain the functionalized polymeric microsphere
Implementation Method 2
exposing the functionalized polymeric microsphere of claim 5 to a radionuclide to allow the radionuclide to be adsorbed on the functionalized polymeric microsphere
Data Source
AI summary
An engineered radioactive polymeric microsphere, and a preparation and application thereof. The preparation method includes: adding a styrene monomer and a disperser and/or a crosslinker into a medium, followed by feeding of nitrogen or helium and stirring to obtain a first reaction mixture; heating the first reaction mixture, and adding an initiator, followed by reaction under stirring at a constant temperature to obtain a second reaction mixture; subjecting the second reaction mixture to washing with ethanol and water, and vacuum drying to obtain a crude polymeric microsphere; subjecting the crude polymeric microsphere to radiation-induced graft polymerization with a functional monomer to obtain the functionalized polymeric microsphere; and exposing the functionalized polymeric microsphere to a radionuclide to prepare the engineered radioactive polymeric microsphere.